159 related articles for article (PubMed ID: 22913544)
1. Bis(arylvinyl)pyrazines, -pyrimidines, and -pyridazines as imaging agents for tau fibrils and β-amyloid plaques in Alzheimer's disease models.
Boländer A; Kieser D; Voss C; Bauer S; Schön C; Burgold S; Bittner T; Hölzer J; Heyny-von Haußen R; Mall G; Goetschy V; Czech C; Knust H; Berger R; Herms J; Hilger I; Schmidt B
J Med Chem; 2012 Nov; 55(21):9170-80. PubMed ID: 22913544
[TBL] [Abstract][Full Text] [Related]
2. Fluorescent 2-styrylpyridazin-3(2H)-one derivatives as probes targeting amyloid-beta plaques in Alzheimer's disease.
Park YD; Park JH; Hur MG; Kim SW; Min JJ; Park SH; Yoo YJ; Yoon YJ; Yang SD
Bioorg Med Chem Lett; 2012 Jun; 22(12):4106-10. PubMed ID: 22578456
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of trimethine cyanine dyes as fluorescent probes for the detection of tau fibrils in Alzheimer's disease brain and olfactory epithelium.
Gu J; Anumala UR; Heyny-von Haußen R; Hölzer J; Goetschy-Meyer V; Mall G; Hilger I; Czech C; Schmidt B
ChemMedChem; 2013 Jun; 8(6):891-7. PubMed ID: 23592568
[TBL] [Abstract][Full Text] [Related]
4. Styryl-based compounds as potential in vivo imaging agents for beta-amyloid plaques.
Li Q; Min J; Ahn YH; Namm J; Kim EM; Lui R; Kim HY; Ji Y; Wu H; Wisniewski T; Chang YT
Chembiochem; 2007 Sep; 8(14):1679-87. PubMed ID: 17705341
[TBL] [Abstract][Full Text] [Related]
5. In vivo detection of amyloid plaques in the mouse brain using the near-infrared fluorescence probe THK-265.
Okamura N; Mori M; Furumoto S; Yoshikawa T; Harada R; Ito S; Fujikawa Y; Arai H; Yanai K; Kudo Y
J Alzheimers Dis; 2011; 23(1):37-48. PubMed ID: 20930313
[TBL] [Abstract][Full Text] [Related]
6. Efficient near-infrared in vivo imaging of amyoid-β deposits in Alzheimer's disease mouse models.
Schmidt A; Pahnke J
J Alzheimers Dis; 2012; 30(3):651-64. PubMed ID: 22460331
[TBL] [Abstract][Full Text] [Related]
7. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM
J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708
[TBL] [Abstract][Full Text] [Related]
8. Fluorescent rhodanine-3-acetic acids visualize neurofibrillary tangles in Alzheimer's disease brains.
Anumala UR; Gu J; Lo Monte F; Kramer T; Heyny-von Haußen R; Hölzer J; Goetschy-Meyer V; Schön C; Mall G; Hilger I; Czech C; Herms J; Schmidt B
Bioorg Med Chem; 2013 Sep; 21(17):5139-44. PubMed ID: 23859773
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo staining characteristics of small, fluorescent, Abeta42-binding D-enantiomeric peptides in transgenic AD mouse models.
van Groen T; Kadish I; Wiesehan K; Funke SA; Willbold D
ChemMedChem; 2009 Feb; 4(2):276-82. PubMed ID: 19072935
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
11. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T
Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
[TBL] [Abstract][Full Text] [Related]
12. Beta-amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes.
David DC; Ittner LM; Gehrig P; Nergenau D; Shepherd C; Halliday G; Götz J
Proteomics; 2006 Dec; 6(24):6566-77. PubMed ID: 17111439
[TBL] [Abstract][Full Text] [Related]
13. Highly Sensitive Near-Infrared Fluorophores for in Vivo Detection of Amyloid-β Plaques in Alzheimer's Disease.
Fu H; Cui M; Zhao L; Tu P; Zhou K; Dai J; Liu B
J Med Chem; 2015 Sep; 58(17):6972-83. PubMed ID: 26262759
[TBL] [Abstract][Full Text] [Related]
14. Spatially pathogenic forms of tau detected in Alzheimer's disease brain tissue by fluorescence lifetime-based Förster resonance energy transfer.
Larionov S; Wielgat P; Wang Y; Thal DR; Neumann H
J Neurosci Methods; 2010 Sep; 192(1):127-37. PubMed ID: 20655329
[TBL] [Abstract][Full Text] [Related]
15. Detection of Aβ plaques by a novel specific MRI probe precursor CR-BSA-(Gd-DTPA)n in APP/PS1 transgenic mice.
Li S; He H; Cui W; Gu B; Li J; Qi Z; Zhou G; Liang CM; Feng XY
Anat Rec (Hoboken); 2010 Dec; 293(12):2136-43. PubMed ID: 21089051
[TBL] [Abstract][Full Text] [Related]
16. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
17. Selecting a mouse model of Alzheimer's disease.
Chin J
Methods Mol Biol; 2011; 670():169-89. PubMed ID: 20967591
[TBL] [Abstract][Full Text] [Related]
18. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
[TBL] [Abstract][Full Text] [Related]
19. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
Güntert A; Döbeli H; Bohrmann B
Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
[TBL] [Abstract][Full Text] [Related]
20. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M
Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
